Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Safety issues associated with Pivanex plus docetaxel in phase IIb study

June 28, 2004

New antitumor agents developed by Sanofi-Synthelabo scientists

June 25, 2004

Roche claims two series of protein kinase inhibitors for use in cancer therapy

June 25, 2004

XenoPort presents new gemcitabine prodrugs

June 25, 2004

Immusol initiates collaboration with Affymetrix for oncology drug discovery

June 25, 2004

FDA lifts clinical hold on phase I NHL study of PPI-2458

June 25, 2004

Good safety profile reported for AP-23573 in patients with refractory tumors

June 25, 2004

New European approval for Herceptin

June 25, 2004

Metabolic conversion of anticancer agent SD-2007 to apicidin in rats

June 25, 2004

Bevacizumab demonstrates substantial clinical activity

June 25, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...